Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 1231 entries
Sorted by: Best Match Show Resources per page
Field experiments of 28 GHz band 5G system at indoor train station platform

field stations

Hasegawa Y, Kanai K.
GSID: wab-h-ShjicJ
M Okano, Y Hasegawa, K Kanai… - 2020 IEEE 17th …, 2020 - ieeexplore.ieee.org

Recently, a fifth-generation cellular system (5G) is widely expected to provide plenty of wireless network resources (ie, broadband capacity). In this paper, to validate 5G system …

Cite
Okano, M., Hasegawa, Y., Kanai, K., Wei, B., & Katton, J. (2020, January). Field experiments of 28 GHz band 5G system at indoor train station platform. In 2020 IEEE 17th Annual Consumer Communications & Networking Conference (CCNC) (pp. 1-6). IEEE.
Okano, Mayuko, et al. "Field experiments of 28 GHz band 5G system at indoor train station platform." 2020 IEEE 17th Annual Consumer Communications & Networking Conference (CCNC). IEEE, 2020.
Copy Download .nbib Format: MLA
Rapid tumor necrosis and massive hemorrhage induced by bevacizumab and paclitaxel combination therapy in a case of advanced breast cancer.

OncoTargets and therapy

Ono M, Ito T, Kanai T, Murayama K, Koyama H, Maeno K, Mochizuki Y, Iesato A, Hanamura T, Okada T, Watanabe T, Ito K.
PMID: 24124381
Onco Targets Ther. 2013 Oct 07;6:1393-8. doi: 10.2147/OTT.S51164. eCollection 2013.

Bevacizumab when combined with chemotherapy exerts significant activity against many solid tumors through tumor angiogenesis inhibition; however, it can induce severe side effects. We report the rare case of a 27-year-old premenopausal woman with locally advanced breast cancer that...

Cite
Ono M, Ito T, Kanai T, et al. Rapid tumor necrosis and massive hemorrhage induced by bevacizumab and paclitaxel combination therapy in a case of advanced breast cancer. Onco Targets Ther. 2013;6:1393-8doi: 10.2147/OTT.S51164.
Ono, M., Ito, T., Kanai, T., Murayama, K., Koyama, H., Maeno, K., Mochizuki, Y., Iesato, A., Hanamura, T., Okada, T., Watanabe, T., & Ito, K. (2013). Rapid tumor necrosis and massive hemorrhage induced by bevacizumab and paclitaxel combination therapy in a case of advanced breast cancer. OncoTargets and therapy, 61393-8. https://doi.org/10.2147/OTT.S51164
Ono, Mayu, et al. "Rapid tumor necrosis and massive hemorrhage induced by bevacizumab and paclitaxel combination therapy in a case of advanced breast cancer." OncoTargets and therapy vol. 6 (2013): 1393-8. doi: https://doi.org/10.2147/OTT.S51164
Ono M, Ito T, Kanai T, Murayama K, Koyama H, Maeno K, Mochizuki Y, Iesato A, Hanamura T, Okada T, Watanabe T, Ito K. Rapid tumor necrosis and massive hemorrhage induced by bevacizumab and paclitaxel combination therapy in a case of advanced breast cancer. Onco Targets Ther. 2013 Oct 07;6:1393-8. doi: 10.2147/OTT.S51164. eCollection 2013. PMID: 24124381; PMCID: PMC3794845.
Copy Download .nbib Format: NLM
Benefit of rebiopsy for deciding treatment strategy in rectal cancer: A case report.

Oncology letters

Kawasaki K, Hamamoto Y, Suzuki T, Hirata K, Sukawa Y, Kasuga A, Hayashi Y, Takaishi H, Kameyama K, Kanai T.
PMID: 28927133
Oncol Lett. 2017 Sep;14(3):3697-3700. doi: 10.3892/ol.2017.6601. Epub 2017 Jul 18.

Rebiopsy is considered an option for specific types of cancer, such as breast, non-small cell lung, and prostate cancer, in clinical trials and in practice. The benefit of rebiopsy comes from the selection of a new treatment strategy based...

Cite
Kawasaki K, Hamamoto Y, Suzuki T, et al. Benefit of rebiopsy for deciding treatment strategy in rectal cancer: A case report. Oncol Lett. 2017;14(3):3697-3700doi: 10.3892/ol.2017.6601.
Kawasaki, K., Hamamoto, Y., Suzuki, T., Hirata, K., Sukawa, Y., Kasuga, A., Hayashi, Y., Takaishi, H., Kameyama, K., & Kanai, T. (2017). Benefit of rebiopsy for deciding treatment strategy in rectal cancer: A case report. Oncology letters, 14(3), 3697-3700. https://doi.org/10.3892/ol.2017.6601
Kawasaki, Kenta, et al. "Benefit of rebiopsy for deciding treatment strategy in rectal cancer: A case report." Oncology letters vol. 14,3 (2017): 3697-3700. doi: https://doi.org/10.3892/ol.2017.6601
Kawasaki K, Hamamoto Y, Suzuki T, Hirata K, Sukawa Y, Kasuga A, Hayashi Y, Takaishi H, Kameyama K, Kanai T. Benefit of rebiopsy for deciding treatment strategy in rectal cancer: A case report. Oncol Lett. 2017 Sep;14(3):3697-3700. doi: 10.3892/ol.2017.6601. Epub 2017 Jul 18. PMID: 28927133; PMCID: PMC5587936.
Copy Download .nbib Format: NLM
Small cell lung cancer transformation during immunotherapy with nivolumab: A case report.

Respiratory medicine case reports

Imakita T, Fujita K, Kanai O, Terashima T, Mio T.
PMID: 28393006
Respir Med Case Rep. 2017 Mar 29;21:52-55. doi: 10.1016/j.rmcr.2017.03.019. eCollection 2017.

We report a rare case of transformation of non-small cell lung cancer (NSCLC) to small cell lung cancer (SCLC), without epidermal growth factor receptor (EGFR) gene mutation, during immunotherapy treatment with nivolumab. A 75-year-old man was referred to our...

Cite
Imakita T, Fujita K, Kanai O, et al. Small cell lung cancer transformation during immunotherapy with nivolumab: A case report. Respir Med Case Rep. 2017;21:52-55doi: 10.1016/j.rmcr.2017.03.019.
Imakita, T., Fujita, K., Kanai, O., Terashima, T., & Mio, T. (2017). Small cell lung cancer transformation during immunotherapy with nivolumab: A case report. Respiratory medicine case reports, 2152-55. https://doi.org/10.1016/j.rmcr.2017.03.019
Imakita, Takuma, et al. "Small cell lung cancer transformation during immunotherapy with nivolumab: A case report." Respiratory medicine case reports vol. 21 (2017): 52-55. doi: https://doi.org/10.1016/j.rmcr.2017.03.019
Imakita T, Fujita K, Kanai O, Terashima T, Mio T. Small cell lung cancer transformation during immunotherapy with nivolumab: A case report. Respir Med Case Rep. 2017 Mar 29;21:52-55. doi: 10.1016/j.rmcr.2017.03.019. eCollection 2017. PMID: 28393006; PMCID: PMC5376266.
Copy Download .nbib Format: NLM
Influence of regular exercise on gastric emptying in healthy men: a pilot study.

Journal of clinical biochemistry and nutrition

Matsuzaki J, Suzuki H, Masaoka T, Tanaka K, Mori H, Kanai T.
PMID: 27698540
J Clin Biochem Nutr. 2016 Sep;59(2):130-133. doi: 10.3164/jcbn.16-29. Epub 2016 Jul 16.

Functional gastrointestinal disorders (FGIDs), including functional dyspepsia (FD), are common chronic disorders even in the younger population. Physical activity is advocated for patients with FGIDs, although the evidence is insufficient. We investigated the association between the intensity of regular...

Cite
Matsuzaki J, Suzuki H, Masaoka T, et al. Influence of regular exercise on gastric emptying in healthy men: a pilot study. J Clin Biochem Nutr. 2016;59(2):130-133doi: 10.3164/jcbn.16-29.
Matsuzaki, J., Suzuki, H., Masaoka, T., Tanaka, K., Mori, H., & Kanai, T. (2016). Influence of regular exercise on gastric emptying in healthy men: a pilot study. Journal of clinical biochemistry and nutrition, 59(2), 130-133. https://doi.org/10.3164/jcbn.16-29
Matsuzaki, Juntaro, et al. "Influence of regular exercise on gastric emptying in healthy men: a pilot study." Journal of clinical biochemistry and nutrition vol. 59,2 (2016): 130-133. doi: https://doi.org/10.3164/jcbn.16-29
Matsuzaki J, Suzuki H, Masaoka T, Tanaka K, Mori H, Kanai T. Influence of regular exercise on gastric emptying in healthy men: a pilot study. J Clin Biochem Nutr. 2016 Sep;59(2):130-133. doi: 10.3164/jcbn.16-29. Epub 2016 Jul 16. PMID: 27698540; PMCID: PMC5018576.
Copy Download .nbib Format: NLM
Methylprednisolone pulse therapy and intravenous cyclophosphamide therapy combined with cocktail therapy in severe pediatric Henoch-Schönlein purpura nephritis patient.

CEN case reports

Kanai H, Kobayashi A, Matsushita K, Sawanobori E, Sugita K, Higashida K.
PMID: 28509230
CEN Case Rep. 2013 May;2(1):117-122. doi: 10.1007/s13730-012-0056-8. Epub 2013 Jan 12.

Henoch-Schönlein purpura (HSP) is a common self-limited vasculitis in children. The long-term prognosis depends on renal involvement. In severe Henoch-Schönlein purpura nephritis (HSPN) patients, >50 % have crescent formation and nephrotic syndrome that are important predicted outcomes. Therefore, for...

Cite
Kanai H, Kobayashi A, Matsushita K, et al. Methylprednisolone pulse therapy and intravenous cyclophosphamide therapy combined with cocktail therapy in severe pediatric Henoch-Schönlein purpura nephritis patient. CEN Case Rep. 2013;2(1):117-122doi: 10.1007/s13730-012-0056-8.
Kanai, H., Kobayashi, A., Matsushita, K., Sawanobori, E., Sugita, K., & Higashida, K. (2013). Methylprednisolone pulse therapy and intravenous cyclophosphamide therapy combined with cocktail therapy in severe pediatric Henoch-Schönlein purpura nephritis patient. CEN case reports, 2(1), 117-122. https://doi.org/10.1007/s13730-012-0056-8
Kanai, Hiroaki, et al. "Methylprednisolone pulse therapy and intravenous cyclophosphamide therapy combined with cocktail therapy in severe pediatric Henoch-Schönlein purpura nephritis patient." CEN case reports vol. 2,1 (2013): 117-122. doi: https://doi.org/10.1007/s13730-012-0056-8
Kanai H, Kobayashi A, Matsushita K, Sawanobori E, Sugita K, Higashida K. Methylprednisolone pulse therapy and intravenous cyclophosphamide therapy combined with cocktail therapy in severe pediatric Henoch-Schönlein purpura nephritis patient. CEN Case Rep. 2013 May;2(1):117-122. doi: 10.1007/s13730-012-0056-8. Epub 2013 Jan 12. PMID: 28509230; PMCID: PMC5411523.
Copy Download .nbib Format: NLM
A Novel Spiro-Heterocyclic Compound Identified by the Silkworm Infection Model Inhibits Transcription in .

Frontiers in microbiology

Paudel A, Hamamoto H, Panthee S, Kaneko K, Matsunaga S, Kanai M, Suzuki Y, Sekimizu K.
PMID: 28487682
Front Microbiol. 2017 Apr 25;8:712. doi: 10.3389/fmicb.2017.00712. eCollection 2017.

Synthetic compounds are a vital source of antimicrobial agents. To uncover therapeutically effective antimicrobial agents from a chemical library, we screened over 100,000 synthetic compounds for

Cite
Paudel A, Hamamoto H, Panthee S, et al. A Novel Spiro-Heterocyclic Compound Identified by the Silkworm Infection Model Inhibits Transcription in . Front Microbiol. 2017;8:712doi: 10.3389/fmicb.2017.00712.
Paudel, A., Hamamoto, H., Panthee, S., Kaneko, K., Matsunaga, S., Kanai, M., Suzuki, Y., & Sekimizu, K. (2017). A Novel Spiro-Heterocyclic Compound Identified by the Silkworm Infection Model Inhibits Transcription in . Frontiers in microbiology, 8712. https://doi.org/10.3389/fmicb.2017.00712
Paudel, Atmika, et al. "A Novel Spiro-Heterocyclic Compound Identified by the Silkworm Infection Model Inhibits Transcription in ." Frontiers in microbiology vol. 8 (2017): 712. doi: https://doi.org/10.3389/fmicb.2017.00712
Paudel A, Hamamoto H, Panthee S, Kaneko K, Matsunaga S, Kanai M, Suzuki Y, Sekimizu K. A Novel Spiro-Heterocyclic Compound Identified by the Silkworm Infection Model Inhibits Transcription in . Front Microbiol. 2017 Apr 25;8:712. doi: 10.3389/fmicb.2017.00712. eCollection 2017. PMID: 28487682; PMCID: PMC5403886.
Copy Download .nbib Format: NLM
High-frame-rate echocardiography using diverging transmit beams and parallel receive beamforming.

Journal of medical ultrasonics (2001)

Hasegawa H, Kanai H.
PMID: 27278500
J Med Ultrason (2001). 2011 Jul;38(3):129-40. doi: 10.1007/s10396-011-0304-0. Epub 2011 May 07.

PURPOSE: Echocardiography is a widely used modality for diagnosis of the heart. It enables observation of the shape of the heart and estimation of global heart function based on B-mode and M-mode imaging. Subsequently, methods for estimating myocardial strain...

Cite
Hasegawa H, Kanai H. High-frame-rate echocardiography using diverging transmit beams and parallel receive beamforming. J Med Ultrason (2001). 2011;38(3):129-40doi: 10.1007/s10396-011-0304-0.
Hasegawa, H., & Kanai, H. (2011). High-frame-rate echocardiography using diverging transmit beams and parallel receive beamforming. Journal of medical ultrasonics (2001), 38(3), 129-40. https://doi.org/10.1007/s10396-011-0304-0
Hasegawa, Hideyuki, and Kanai, Hiroshi. "High-frame-rate echocardiography using diverging transmit beams and parallel receive beamforming." Journal of medical ultrasonics (2001) vol. 38,3 (2011): 129-40. doi: https://doi.org/10.1007/s10396-011-0304-0
Hasegawa H, Kanai H. High-frame-rate echocardiography using diverging transmit beams and parallel receive beamforming. J Med Ultrason (2001). 2011 Jul;38(3):129-40. doi: 10.1007/s10396-011-0304-0. Epub 2011 May 07. PMID: 27278500.
Copy Download .nbib Format: NLM
Editor's Notes.

Journal of medical ultrasonics (2001)

Kanai H.
PMID: 27279122
J Med Ultrason (2001). 2012 Oct;39(4):293. doi: 10.1007/s10396-012-0395-2.

No abstract available.

Cite
Kanai H. Editor's Notes. J Med Ultrason (2001). 2012;39(4):293doi: 10.1007/s10396-012-0395-2.
Kanai, H. (2012). Editor's Notes. Journal of medical ultrasonics (2001), 39(4), 293. https://doi.org/10.1007/s10396-012-0395-2
Kanai, Hiroshi. "Editor's Notes." Journal of medical ultrasonics (2001) vol. 39,4 (2012): 293. doi: https://doi.org/10.1007/s10396-012-0395-2
Kanai H. Editor's Notes. J Med Ultrason (2001). 2012 Oct;39(4):293. doi: 10.1007/s10396-012-0395-2. PMID: 27279122.
Copy Download .nbib Format: NLM
Severe panuveitis in neuro-Behçet's disease in Malaysia: a case series.

International medical case reports journal

Othman K, Liza-Sharmini AT, Ibrahim M, Tharakan J, Yanai R, Zunaina E.
PMID: 28223848
Int Med Case Rep J. 2017 Feb 07;10:35-40. doi: 10.2147/IMCRJ.S121863. eCollection 2017.

Behçet's disease (BD) is a multisystemic disease that is very rare in Malaysia. About 5% of patients develop central nervous system involvement, termed neuro-Behçet's. Neuro-Behçet's is one of the most serious causes of long-term morbidity and mortality. We report...

Cite
Othman K, Liza-Sharmini AT, Ibrahim M, et al. Severe panuveitis in neuro-Behçet's disease in Malaysia: a case series. Int Med Case Rep J. 2017;10:35-40doi: 10.2147/IMCRJ.S121863.
Othman, K., Liza-Sharmini, A. T., Ibrahim, M., Tharakan, J., Yanai, R., & Zunaina, E. (2017). Severe panuveitis in neuro-Behçet's disease in Malaysia: a case series. International medical case reports journal, 1035-40. https://doi.org/10.2147/IMCRJ.S121863
Othman, Khairuddin, et al. "Severe panuveitis in neuro-Behçet's disease in Malaysia: a case series." International medical case reports journal vol. 10 (2017): 35-40. doi: https://doi.org/10.2147/IMCRJ.S121863
Othman K, Liza-Sharmini AT, Ibrahim M, Tharakan J, Yanai R, Zunaina E. Severe panuveitis in neuro-Behçet's disease in Malaysia: a case series. Int Med Case Rep J. 2017 Feb 07;10:35-40. doi: 10.2147/IMCRJ.S121863. eCollection 2017. PMID: 28223848; PMCID: PMC5304997.
Copy Download .nbib Format: NLM
Initial response to sorafenib by using enhancement criteria in patients with hepatocellular carcinoma.

Hepatology international

Ogasawara S, Kanai F, Ooka Y, Motoyama T, Suzuki E, Tawada A, Chiba T, Yokosuka O.
PMID: 26201804
Hepatol Int. 2013 Jun;7(2):703-13. doi: 10.1007/s12072-013-9425-4. Epub 2013 Feb 12.

PURPOSE: Sorafenib induces early vascularity reduction in patients with hepatocellular carcinoma (HCC). We sought to identify differences in radiological assessment approaches and to evaluate their usefulness for the prediction of the initial response to sorafenib.METHODS: Forty-eight patients with advanced...

Cite
Ogasawara S, Kanai F, Ooka Y, et al. Initial response to sorafenib by using enhancement criteria in patients with hepatocellular carcinoma. Hepatol Int. 2013;7(2):703-13doi: 10.1007/s12072-013-9425-4.
Ogasawara, S., Kanai, F., Ooka, Y., Motoyama, T., Suzuki, E., Tawada, A., Chiba, T., & Yokosuka, O. (2013). Initial response to sorafenib by using enhancement criteria in patients with hepatocellular carcinoma. Hepatology international, 7(2), 703-13. https://doi.org/10.1007/s12072-013-9425-4
Ogasawara, Sadahisa, et al. "Initial response to sorafenib by using enhancement criteria in patients with hepatocellular carcinoma." Hepatology international vol. 7,2 (2013): 703-13. doi: https://doi.org/10.1007/s12072-013-9425-4
Ogasawara S, Kanai F, Ooka Y, Motoyama T, Suzuki E, Tawada A, Chiba T, Yokosuka O. Initial response to sorafenib by using enhancement criteria in patients with hepatocellular carcinoma. Hepatol Int. 2013 Jun;7(2):703-13. doi: 10.1007/s12072-013-9425-4. Epub 2013 Feb 12. PMID: 26201804.
Copy Download .nbib Format: NLM
Early tumor cavitation with regorafenib in metastatic colorectal cancer: A case report.

Oncology letters

Kawasaki K, Hamamoto Y, Adachi M, Kanai T, Takaishi H.
PMID: 26870193
Oncol Lett. 2016 Jan;11(1):231-233. doi: 10.3892/ol.2015.3905. Epub 2015 Nov 10.

Tumoral cavity formation is a characteristic phenomenon reported in anti-angiogenic therapy in lung lesions. A 57-year-old male with multiple pulmonary metastases from colorectal cancer treated with an oral tyrosine kinase inhibitor, regorafenib, exhibited a characteristic cavity formation after the...

Cite
Kawasaki K, Hamamoto Y, Adachi M, et al. Early tumor cavitation with regorafenib in metastatic colorectal cancer: A case report. Oncol Lett. 2015;11(1):231-233doi: 10.3892/ol.2015.3905.
Kawasaki, K., Hamamoto, Y., Adachi, M., Kanai, T., & Takaishi, H. (2016). Early tumor cavitation with regorafenib in metastatic colorectal cancer: A case report. Oncology letters, 11(1), 231-233. https://doi.org/10.3892/ol.2015.3905
Kawasaki, Kenta, et al. "Early tumor cavitation with regorafenib in metastatic colorectal cancer: A case report." Oncology letters vol. 11,1 (2016): 231-233. doi: https://doi.org/10.3892/ol.2015.3905
Kawasaki K, Hamamoto Y, Adachi M, Kanai T, Takaishi H. Early tumor cavitation with regorafenib in metastatic colorectal cancer: A case report. Oncol Lett. 2016 Jan;11(1):231-233. doi: 10.3892/ol.2015.3905. Epub 2015 Nov 10. PMID: 26870193; PMCID: PMC4727027.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 1231 entries